Skip to main content
Top
Published in: Diabetologia 5/2010

Open Access 01-05-2010 | Article

Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes

Authors: M. Sasaki, Y. Ozawa, T. Kurihara, S. Kubota, K. Yuki, K. Noda, S. Kobayashi, S. Ishida, K. Tsubota

Published in: Diabetologia | Issue 5/2010

Login to get access

Abstract

Aims/hypothesis

Diabetic retinopathy is a progressive neurodegenerative disease, but the underlying mechanism is still obscure. Here, we focused on oxidative stress in the retina, and analysed its influence on retinal neurodegeneration, using an antioxidant, lutein.

Methods

C57BL/6 mice with streptozotocin-induced diabetes were constantly fed either a lutein-supplemented diet or a control diet from the onset of diabetes, and their metabolic data were recorded. In 1-month-diabetic mice, reactive oxygen species (ROS) in the retina were measured using dihydroethidium and visual function was evaluated by electroretinograms. Levels of activated extracellular signal-regulated kinase (ERK), synaptophysin and brain-derived neurotrophic factor (BDNF) were also measured by immunoblotting in the retina of 1-month-diabetic mice. In the retinal sections of 4-month-diabetic mice, histological changes, cleaved caspase-3 and TUNEL staining were analysed.

Results

Lutein did not affect the metabolic status of the diabetic mice, but it prevented ROS generation in the retina and the visual impairment induced by diabetes. ERK activation, the subsequent synaptophysin reduction, and the BDNF depletion in the diabetic retina were all prevented by lutein. Later, in 4-month-diabetic mice, a decrease in the thickness of the inner plexiform and nuclear layers, and ganglion cell number, together with increase in cleaved caspase-3- and TUNEL-positive cells, were avoided in the retina of lutein-fed mice.

Conclusions/interpretation

The results indicated that local oxidative stress that has a neurodegenerative influence in the diabetic retina is prevented by constant intake of a lutein-supplemented diet. The antioxidant, lutein may be a potential therapeutic approach to protect visual function in diabetes.
Literature
1.
go back to reference Barber AJ (2003) A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry 27:283–290CrossRefPubMed Barber AJ (2003) A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry 27:283–290CrossRefPubMed
2.
go back to reference Dandona P, Thusu K, Cook S et al (1996) Oxidative damage to DNA in diabetes mellitus. Lancet 347:444–445CrossRefPubMed Dandona P, Thusu K, Cook S et al (1996) Oxidative damage to DNA in diabetes mellitus. Lancet 347:444–445CrossRefPubMed
3.
go back to reference Lee HB, Yu MR, Yang Y, Jiang Z, Ha H (2003) Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol 14:S241–S245CrossRefPubMed Lee HB, Yu MR, Yang Y, Jiang Z, Ha H (2003) Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol 14:S241–S245CrossRefPubMed
4.
go back to reference Zheng L, Du Y, Miller C et al (2007) Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes. Diabetologia 50:1987–1996CrossRefPubMed Zheng L, Du Y, Miller C et al (2007) Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes. Diabetologia 50:1987–1996CrossRefPubMed
5.
go back to reference Rivero A, Mora C, Muros M, Garcia J, Herrera H, Navarro-Gonzalez JF (2009) Pathogenic perspectives for the role of inflammation in diabetic nephropathy. Clin Sci (Lond) 116:479–492CrossRef Rivero A, Mora C, Muros M, Garcia J, Herrera H, Navarro-Gonzalez JF (2009) Pathogenic perspectives for the role of inflammation in diabetic nephropathy. Clin Sci (Lond) 116:479–492CrossRef
6.
go back to reference Sasaki M, Ozawa Y, Kurihara T et al (2009) Neuroprotective effect of an antioxidant, lutein, during retinal inflammation. Invest Ophthalmol Vis Sci 50:1433–1439CrossRefPubMed Sasaki M, Ozawa Y, Kurihara T et al (2009) Neuroprotective effect of an antioxidant, lutein, during retinal inflammation. Invest Ophthalmol Vis Sci 50:1433–1439CrossRefPubMed
7.
go back to reference Izumi-Nagai K, Nagai N, Ohgami K et al (2007) Macular pigment lutein is antiinflammatory in preventing choroidal neovascularization. Arterioscler Thromb Vasc Biol 27:2555–2562CrossRefPubMed Izumi-Nagai K, Nagai N, Ohgami K et al (2007) Macular pigment lutein is antiinflammatory in preventing choroidal neovascularization. Arterioscler Thromb Vasc Biol 27:2555–2562CrossRefPubMed
8.
go back to reference Kurihara T, Ozawa Y, Nagai N et al (2008) Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina. Diabetes 57:2191–2198CrossRefPubMed Kurihara T, Ozawa Y, Nagai N et al (2008) Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina. Diabetes 57:2191–2198CrossRefPubMed
9.
go back to reference Bui BV, Armitage JA, Tolcos M, Cooper ME, Vingrys AJ (2003) ACE inhibition salvages the visual loss caused by diabetes. Diabetologia 46:401–408PubMed Bui BV, Armitage JA, Tolcos M, Cooper ME, Vingrys AJ (2003) ACE inhibition salvages the visual loss caused by diabetes. Diabetologia 46:401–408PubMed
10.
go back to reference Dong CJ, Agey P, Hare WA (2004) Origins of the electroretinogram oscillatory potentials in the rabbit retina. Vis Neurosci 21:533–543CrossRefPubMed Dong CJ, Agey P, Hare WA (2004) Origins of the electroretinogram oscillatory potentials in the rabbit retina. Vis Neurosci 21:533–543CrossRefPubMed
11.
go back to reference Kizawa J, Machida S, Kobayashi T, Gotoh Y, Kurosaka D (2006) Changes of oscillatory potentials and photopic negative response in patients with early diabetic retinopathy. Jpn J Ophthalmol 50:367–373CrossRefPubMed Kizawa J, Machida S, Kobayashi T, Gotoh Y, Kurosaka D (2006) Changes of oscillatory potentials and photopic negative response in patients with early diabetic retinopathy. Jpn J Ophthalmol 50:367–373CrossRefPubMed
12.
go back to reference Hancock HA, Kraft TW (2004) Oscillatory potential analysis and ERGs of normal and diabetic rats. Invest Ophthalmol Vis Sci 45:1002–1008CrossRefPubMed Hancock HA, Kraft TW (2004) Oscillatory potential analysis and ERGs of normal and diabetic rats. Invest Ophthalmol Vis Sci 45:1002–1008CrossRefPubMed
13.
go back to reference Shirao Y, Kawasaki K (1998) Electrical responses from diabetic retina. Prog Retin Eye Res 17:59–76CrossRefPubMed Shirao Y, Kawasaki K (1998) Electrical responses from diabetic retina. Prog Retin Eye Res 17:59–76CrossRefPubMed
14.
go back to reference Kurihara T, Ozawa Y, Shinoda K et al (2006) Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation. Invest Ophthalmol Vis Sci 47:5545–5552CrossRefPubMed Kurihara T, Ozawa Y, Shinoda K et al (2006) Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation. Invest Ophthalmol Vis Sci 47:5545–5552CrossRefPubMed
15.
go back to reference Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW (1998) Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 102:783–791CrossRefPubMed Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW (1998) Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 102:783–791CrossRefPubMed
16.
go back to reference Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB (2004) Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci 45:3330–3336CrossRefPubMed Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB (2004) Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci 45:3330–3336CrossRefPubMed
17.
18.
go back to reference Ali TK, Matragoon S, Pillai BA, Liou GI, El-Remessy AB (2008) Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes. Diabetes 57:889–898CrossRefPubMed Ali TK, Matragoon S, Pillai BA, Liou GI, El-Remessy AB (2008) Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes. Diabetes 57:889–898CrossRefPubMed
19.
go back to reference Seki M, Tanaka T, Nawa H et al (2004) Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells. Diabetes 53:2412–2419CrossRefPubMed Seki M, Tanaka T, Nawa H et al (2004) Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells. Diabetes 53:2412–2419CrossRefPubMed
20.
go back to reference Curran-Celentano J, Hammond BR Jr, Ciulla TA, Cooper DA, Pratt LM, Danis RB (2001) Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population. Am J Clin Nutr 74:796–802PubMed Curran-Celentano J, Hammond BR Jr, Ciulla TA, Cooper DA, Pratt LM, Danis RB (2001) Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population. Am J Clin Nutr 74:796–802PubMed
21.
go back to reference Dwyer JH, Navab M, Dwyer KM et al (2001) Oxygenated carotenoid lutein and progression of early atherosclerosis: the Los Angeles Atherosclerosis Study. Circulation 103:2922–2927PubMed Dwyer JH, Navab M, Dwyer KM et al (2001) Oxygenated carotenoid lutein and progression of early atherosclerosis: the Los Angeles Atherosclerosis Study. Circulation 103:2922–2927PubMed
22.
go back to reference Broekmans WM, Berendschot TT, Klopping-Ketelaars IA et al (2002) Macular pigment density in relation to serum and adipose tissue concentrations of lutein and serum concentrations of zeaxanthin. Am J Clin Nutr 76:595–603PubMed Broekmans WM, Berendschot TT, Klopping-Ketelaars IA et al (2002) Macular pigment density in relation to serum and adipose tissue concentrations of lutein and serum concentrations of zeaxanthin. Am J Clin Nutr 76:595–603PubMed
23.
go back to reference Ozawa Y, Nakao K, Kurihara T et al (2008) Roles of STAT3/SOCS3 pathway in regulating the visual function and ubiquitin–proteasome-dependent degradation of rhodopsin during retinal inflammation. J Biol Chem 283:24561–24570CrossRefPubMed Ozawa Y, Nakao K, Kurihara T et al (2008) Roles of STAT3/SOCS3 pathway in regulating the visual function and ubiquitin–proteasome-dependent degradation of rhodopsin during retinal inflammation. J Biol Chem 283:24561–24570CrossRefPubMed
24.
go back to reference Sundelin SP, Nilsson SE (2001) Lipofuscin-formation in retinal pigment epithelial cells is reduced by antioxidants. Free Radic Biol Med 31:217–225CrossRefPubMed Sundelin SP, Nilsson SE (2001) Lipofuscin-formation in retinal pigment epithelial cells is reduced by antioxidants. Free Radic Biol Med 31:217–225CrossRefPubMed
25.
go back to reference Jin XH, Ohgami K, Shiratori K et al (2006) Inhibitory effects of lutein on endotoxin-induced uveitis in Lewis rats. Invest Ophthalmol Vis Sci 47:2562–2568CrossRefPubMed Jin XH, Ohgami K, Shiratori K et al (2006) Inhibitory effects of lutein on endotoxin-induced uveitis in Lewis rats. Invest Ophthalmol Vis Sci 47:2562–2568CrossRefPubMed
26.
go back to reference Nishikawa T, Edelstein D, Du XL et al (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787–790CrossRefPubMed Nishikawa T, Edelstein D, Du XL et al (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787–790CrossRefPubMed
27.
go back to reference Snodderly DM, Auran JD, Delori FC (1984) The macular pigment. II. Spatial distribution in primate retinas. Invest Ophthalmol Vis Sci 25:674–685PubMed Snodderly DM, Auran JD, Delori FC (1984) The macular pigment. II. Spatial distribution in primate retinas. Invest Ophthalmol Vis Sci 25:674–685PubMed
28.
go back to reference Snodderly DM, Brown PK, Delori FC, Auran JD (1984) The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci 25:660–673PubMed Snodderly DM, Brown PK, Delori FC, Auran JD (1984) The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci 25:660–673PubMed
29.
go back to reference Berka JL, Stubbs AJ, Wang DZ et al (1995) Renin-containing Muller cells of the retina display endocrine features. Invest Ophthalmol Vis Sci 36:1450–1458PubMed Berka JL, Stubbs AJ, Wang DZ et al (1995) Renin-containing Muller cells of the retina display endocrine features. Invest Ophthalmol Vis Sci 36:1450–1458PubMed
30.
go back to reference Wachtmeister L (1998) Oscillatory potentials in the retina: what do they reveal. Prog Retin Eye Res 17:485–521CrossRefPubMed Wachtmeister L (1998) Oscillatory potentials in the retina: what do they reveal. Prog Retin Eye Res 17:485–521CrossRefPubMed
31.
go back to reference Heynen H, Wachtmeister L, van Norren D (1985) Origin of the oscillatory potentials in the primate retina. Vision Res 25:1365–1373CrossRefPubMed Heynen H, Wachtmeister L, van Norren D (1985) Origin of the oscillatory potentials in the primate retina. Vision Res 25:1365–1373CrossRefPubMed
32.
go back to reference Yonemura D, Kawasaki K (1979) New approaches to ophthalmic electrodiagnosis by retinal oscillatory potential, drug-induced responses from retinal pigment epithelium and cone potential. Doc Ophthalmol 48:163–222CrossRefPubMed Yonemura D, Kawasaki K (1979) New approaches to ophthalmic electrodiagnosis by retinal oscillatory potential, drug-induced responses from retinal pigment epithelium and cone potential. Doc Ophthalmol 48:163–222CrossRefPubMed
33.
go back to reference Spiwoks-Becker I, Vollrath L, Seeliger MW, Jaissle G, Eshkind LG, Leube RE (2001) Synaptic vesicle alterations in rod photoreceptors of synaptophysin-deficient mice. Neuroscience 107:127–142CrossRefPubMed Spiwoks-Becker I, Vollrath L, Seeliger MW, Jaissle G, Eshkind LG, Leube RE (2001) Synaptic vesicle alterations in rod photoreceptors of synaptophysin-deficient mice. Neuroscience 107:127–142CrossRefPubMed
34.
go back to reference Dudek H, Datta SR, Franke TF et al (1997) Regulation of neuronal survival by the serine–threonine protein kinase Akt. Science 275:661–665CrossRefPubMed Dudek H, Datta SR, Franke TF et al (1997) Regulation of neuronal survival by the serine–threonine protein kinase Akt. Science 275:661–665CrossRefPubMed
35.
go back to reference Ikegami K, Koike T (2000) Membrane depolarization-mediated survival of sympathetic neurons occurs through both phosphatidylinositol 3-kinase-and CaM kinase II-dependent pathways. Brain Res 866:218–226CrossRefPubMed Ikegami K, Koike T (2000) Membrane depolarization-mediated survival of sympathetic neurons occurs through both phosphatidylinositol 3-kinase-and CaM kinase II-dependent pathways. Brain Res 866:218–226CrossRefPubMed
36.
go back to reference Sano M, Fukuda K, Sato T et al (2001) ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts. Circ Res 89:661–669CrossRefPubMed Sano M, Fukuda K, Sato T et al (2001) ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts. Circ Res 89:661–669CrossRefPubMed
37.
go back to reference Kohara K, Kitamura A, Morishima M, Tsumoto T (2001) Activity-dependent transfer of brain-derived neurotrophic factor to postsynaptic neurons. Science 291:2419–2423CrossRefPubMed Kohara K, Kitamura A, Morishima M, Tsumoto T (2001) Activity-dependent transfer of brain-derived neurotrophic factor to postsynaptic neurons. Science 291:2419–2423CrossRefPubMed
38.
39.
go back to reference Lohof AM, Ip NY, Poo MM (1993) Potentiation of developing neuromuscular synapses by the neurotrophins NT-3 and BDNF. Nature 363:350–353CrossRefPubMed Lohof AM, Ip NY, Poo MM (1993) Potentiation of developing neuromuscular synapses by the neurotrophins NT-3 and BDNF. Nature 363:350–353CrossRefPubMed
40.
go back to reference Johnson JE, Barde YA, Schwab M, Thoenen H (1986) Brain-derived neurotrophic factor supports the survival of cultured rat retinal ganglion cells. J Neurosci 6:3031–3038PubMed Johnson JE, Barde YA, Schwab M, Thoenen H (1986) Brain-derived neurotrophic factor supports the survival of cultured rat retinal ganglion cells. J Neurosci 6:3031–3038PubMed
41.
go back to reference Barber AJ, Antonetti DA, Kern TS et al (2005) The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci 46:2210–2218CrossRefPubMed Barber AJ, Antonetti DA, Kern TS et al (2005) The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci 46:2210–2218CrossRefPubMed
42.
go back to reference Gastinger MJ, Singh RS, Barber AJ (2006) Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas. Invest Ophthalmol Vis Sci 47:3143–3150CrossRefPubMed Gastinger MJ, Singh RS, Barber AJ (2006) Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas. Invest Ophthalmol Vis Sci 47:3143–3150CrossRefPubMed
43.
go back to reference Zhan SS, Beyreuther K, Schmitt HP (1993) Quantitative assessment of the synaptophysin immuno-reactivity of the cortical neuropil in various neurodegenerative disorders with dementia. Dementia 4:66–74PubMed Zhan SS, Beyreuther K, Schmitt HP (1993) Quantitative assessment of the synaptophysin immuno-reactivity of the cortical neuropil in various neurodegenerative disorders with dementia. Dementia 4:66–74PubMed
44.
go back to reference Phillips HS, Hains JM, Armanini M, Laramee GR, Johnson SA, Winslow JW (1991) BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer’s disease. Neuron 7:695–702CrossRefPubMed Phillips HS, Hains JM, Armanini M, Laramee GR, Johnson SA, Winslow JW (1991) BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer’s disease. Neuron 7:695–702CrossRefPubMed
46.
go back to reference Ozawa Y, Ishida S, Tsubota K (2008) Age-related macular degeneration (AMD); from pathogenesis and approved therapies to proposed treatments for prevention. Anti-Aging Medicine 5:81–82CrossRef Ozawa Y, Ishida S, Tsubota K (2008) Age-related macular degeneration (AMD); from pathogenesis and approved therapies to proposed treatments for prevention. Anti-Aging Medicine 5:81–82CrossRef
47.
go back to reference Brazionis L, Rowley K, Itsiopoulos C, O’Dea K (2009) Plasma carotenoids and diabetic retinopathy. Br J Nutr 101:270–277CrossRefPubMed Brazionis L, Rowley K, Itsiopoulos C, O’Dea K (2009) Plasma carotenoids and diabetic retinopathy. Br J Nutr 101:270–277CrossRefPubMed
Metadata
Title
Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes
Authors
M. Sasaki
Y. Ozawa
T. Kurihara
S. Kubota
K. Yuki
K. Noda
S. Kobayashi
S. Ishida
K. Tsubota
Publication date
01-05-2010
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 5/2010
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1655-6

Other articles of this Issue 5/2010

Diabetologia 5/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.